Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Cellbyte Raises $2.75 Million to Cut Pharmaceutical Drug Launch Timelines in Half with AI
Cellbyte, the AI-native platform that helps pharmaceutical companies accelerate drug launches, announces that it has raised $2.75 million in seed funding. The round was led by Frontline Ventures, with participation from Y Combinator, Pace Ventures, Saras Capital, and Springboard Health Angels.
The messy data landscape in the pharmaceutical industry means that newly developed, life-saving drugs can take over a year to get into the hands of patients who need them. Market Access teams have a laborious task producing documentation for regulatory approval, as well as drug pricing and reimbursement strategies. As a result, pharmaceutical companies often spend hundreds of thousands of dollars to access essential pricing and market data or hire third-party support to complete it.
Cellbyte has developed an AI-native platform for teams involved in drug launches, which allows them to effortlessly analyse millions of data points in real time across clinical, pricing, HTA and regulatory data, as well as internal company sources. By providing fast, reliable and high-quality insights, Cellbyte helps prepare documents, determine effective launch sequences and go-to-market strategies at a dramatically reduced timeline.
Legacy databases were built before the LLM era and only surface the most accessible layer of data, missing the depth that pricing and market access teams need…
Full release here, originally announced November 18th, 2025.
With a $2.5B Valuation, Function Becomes the New Standard for Health and Launches Medical Intelligence Lab
Function established a new category of health that’s shifting people’s approach to quality and length of life. On a mission to empower people to live 100 healthy years, the company started by redefining health with its now popular 160+ lab test membership, enabling individuals to capture a far deeper understanding of their ever-changing bodies. After acquiring Ezra, Function doubled down on its mission by making advanced MRI and CT scans as accessible and proactive as lab testing.
To further democratize health, Function is lowering its annual membership to $365 – $1/day – making what was once $499 even more accessible for anyone to take ownership of their health.
Since 2023, Function members have completed over 50 million lab tests, a proxy for the mainstream adoption of this new approach to lifelong health. Recently named a TIME100 Most Influential Company, Function is helping people feel their best and detect conditions early, including cancers, heart disease, diabetes, thyroid disorders, hormonal imbalances, and more.
Today, the company unveils its Medical IntelligenceLab (MI Lab)…
Full release here, originally announced November 19th, 2025.
Arbiter Emerges from Stealth with $52M to Build the AI System that Connects Healthcare
Arbiter today emerged from stealth with $52 million in funding and a bold mission: to end healthcare fragmentation by uniting payers, providers, and patients on an AI-powered care orchestration platform. Led by TriEdge Investments and MFO Ventures, together with leading private equity firm WindRose Health Investors and other seasoned operators, this financing values Arbiter at $400 million and underscores investor conviction that healthcare needs a connected infrastructure built for real-time collaboration.
Effective patient care depends on coordination, yet today, providers, payers, and patients operate in silos. The fallout is staggering: nearly one trillion dollars in annual waste and patients waiting months or abandoning care altogether. For a patient flagged at high risk for colon cancer, this can mean the difference between early detection and a late-stage diagnosis.
Arbiter ends fragmentation by bringing together data, technology, and stakeholders to close care gaps and intelligently direct next best actions – starting with real-time site-of-care optimization. The platform connects the people and systems that shape every care decision, creating a ripple effect that streamlines coordination and ensures patients move seamlessly from detection to resolution without delay.
“Arbiter’s mission is nothing less than to rebuild the operating spine of U.S. healthcare,” said Michelle Carnahan, Co-Founder and CEO at Arbiter…
Full release here, originally announced November 19th, 2025.
No comments:
Post a Comment